6

uk.cisbio.eu · CTLA-4 (CD152) CTLA-4(CD152) LAG3 (CD 223) CD47 A2AR . T CELL SIGNALING TCR CD3 NE-AT DC 4/8 API CTLA4 PDI SHPI CD28 CD40L Inhibitory Stimulatory Cisbio cell signaling

Download PDF Report

Upload
others
View
1
Download
0

Embed Size (px)

Citation preview

Page 1: uk.cisbio.eu · CTLA-4 (CD152) CTLA-4(CD152) LAG3 (CD 223) CD47 A2AR . T CELL SIGNALING TCR CD3 NE-AT DC 4/8 API CTLA4 PDI SHPI CD28 CD40L Inhibitory Stimulatory Cisbio cell signaling

http://www.cisbio.com/immuno-oncology

Page 2: uk.cisbio.eu · CTLA-4 (CD152) CTLA-4(CD152) LAG3 (CD 223) CD47 A2AR . T CELL SIGNALING TCR CD3 NE-AT DC 4/8 API CTLA4 PDI SHPI CD28 CD40L Inhibitory Stimulatory Cisbio cell signaling

http://www.cisbio.com/immuno-oncology

Page 3: uk.cisbio.eu · CTLA-4 (CD152) CTLA-4(CD152) LAG3 (CD 223) CD47 A2AR . T CELL SIGNALING TCR CD3 NE-AT DC 4/8 API CTLA4 PDI SHPI CD28 CD40L Inhibitory Stimulatory Cisbio cell signaling

http://www.cisbio.com/immuno-oncology

Page 4: uk.cisbio.eu · CTLA-4 (CD152) CTLA-4(CD152) LAG3 (CD 223) CD47 A2AR . T CELL SIGNALING TCR CD3 NE-AT DC 4/8 API CTLA4 PDI SHPI CD28 CD40L Inhibitory Stimulatory Cisbio cell signaling

http://www.cisbio.com/immuno-oncology

Page 5: uk.cisbio.eu · CTLA-4 (CD152) CTLA-4(CD152) LAG3 (CD 223) CD47 A2AR . T CELL SIGNALING TCR CD3 NE-AT DC 4/8 API CTLA4 PDI SHPI CD28 CD40L Inhibitory Stimulatory Cisbio cell signaling

http://www.cisbio.com/immuno-oncology

Page 6: uk.cisbio.eu · CTLA-4 (CD152) CTLA-4(CD152) LAG3 (CD 223) CD47 A2AR . T CELL SIGNALING TCR CD3 NE-AT DC 4/8 API CTLA4 PDI SHPI CD28 CD40L Inhibitory Stimulatory Cisbio cell signaling

http://www.cisbio.com/immuno-oncology

MGD019, a PD-1 x CTLA-4 Tetravalent Bispecific DART Protein,

MGD019, a PD-1 x CTLA-4 Tetravalent Bispecific DART Protein,

Documents

Documents

Expression von CD152 (CTLA-4) auf T-Lymphozyten im …ediss.sub.uni-hamburg.de/.../elektr._Diss._Tsianakas_13-06-2008.pdf · der Universität Hamburg am: 03.06.2008 ... 2.8.4 Messung

Expression von CD152 (CTLA-4) auf T-Lymphozyten im …ediss.sub.uni-hamburg.de/.../elektr._Diss._Tsianakas_13-06-2008.pdf · der Universität Hamburg am: 03.06.2008 ... 2.8.4 Messung

Documents

CD28/CTLA-4/ICOS haplotypes confers susceptibility to ...Endocrine (2017) 55:186–199 DOI 10.1007/s12020-016-1096-1 ORIGINAL ARTICLE CD28/CTLA-4/ICOS haplotypes confers susceptibility

CD28/CTLA-4/ICOS haplotypes confers susceptibility to ...Endocrine (2017) 55:186–199 DOI 10.1007/s12020-016-1096-1 ORIGINAL ARTICLE CD28/CTLA-4/ICOS haplotypes confers susceptibility

Documents

2011 CTLA Annual Conference

2011 CTLA Annual Conference

Documents

Suppressing T cell motility induced by anti–CTLA-4 ... · by anti–CTLA-4 monotherapy improves antitumor effects Maria Grazia Ruocco,1,2 Karsten A. Pilones,1 Noriko Kawashima,1

Suppressing T cell motility induced by anti–CTLA-4 ... · by anti–CTLA-4 monotherapy improves antitumor effects Maria Grazia Ruocco,1,2 Karsten A. Pilones,1 Noriko Kawashima,1

Documents

CTLA 2014 anatomy of DUI trial

CTLA 2014 anatomy of DUI trial

Education

CTLA Forum Spring 2006 · 6/1/2007 · Winter2008 • Vol25/No.3 • CTLA Forum 137 ForCT uLAm Ringinginthe NewYear—2008 How are we doing so far? Thearrivalofanewyear representsatimeforreview,

CTLA Forum Spring 2006 · 6/1/2007 · Winter2008 • Vol25/No.3 • CTLA Forum 137 ForCT uLAm Ringinginthe NewYear—2008 How are we doing so far? Thearrivalofanewyear representsatimeforreview,

Documents

Quarterly Health Topics Series Sanofi’s Vision in Oncology · 2016 2020 2025 Source: IMS Health European Thought Leadership PD-1/PD-L1 PD-1/PD-L1 PD-1/PD-L1 CTLA-4 CTLA-4 CTLA-4

Quarterly Health Topics Series Sanofi’s Vision in Oncology · 2016 2020 2025 Source: IMS Health European Thought Leadership PD-1/PD-L1 PD-1/PD-L1 PD-1/PD-L1 CTLA-4 CTLA-4 CTLA-4

Documents

Millennials Cathleen Burns CTLA - Anaheim August 2008

Millennials Cathleen Burns CTLA - Anaheim August 2008

Documents

ctla - módulo 1.pptx

ctla - módulo 1.pptx

Documents

CTLA-4 controls follicular helper T-cell differentiation by … · CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement Chun Jing

CTLA-4 controls follicular helper T-cell differentiation by … · CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement Chun Jing

Documents

Immuno-oncologytools.thermofisher.com/content/sfs/brochures/PPX_IO_PLF.pdf · Immuno-oncology checkpoint molecules CD152/CTLA-4 Cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibits

Immuno-oncologytools.thermofisher.com/content/sfs/brochures/PPX_IO_PLF.pdf · Immuno-oncology checkpoint molecules CD152/CTLA-4 Cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibits

Documents

CTLA-4 controls the thymic development of both conventional and … · CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the

CTLA-4 controls the thymic development of both conventional and … · CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the

Documents

ABATECEPT (CTLA 4 I g) PRESENTACIÒN

ABATECEPT (CTLA 4 I g) PRESENTACIÒN

Documents

Increased production of soluble CTLA-4 in patients with - HAL

Increased production of soluble CTLA-4 in patients with - HAL

Documents

nd Edition Immune Regulation Proteins · B7-H4, VISTA (B7-H5) and B7-H7, and four known members of the CD28 family: CD28, CTLA-4 (CD152), ICOS, PD-1. The impor- tance of the B7-CD28

nd Edition Immune Regulation Proteins · B7-H4, VISTA (B7-H5) and B7-H7, and four known members of the CD28 family: CD28, CTLA-4 (CD152), ICOS, PD-1. The impor- tance of the B7-CD28

Documents

Increased frequency of ICOS for anti-CTLA-4 therapycancerimmunolres.aacrjournals.org/content/canimm/early/2013/07/31/... · biomarker for anti-CTLA-4 therapy, ... and red blood cells

Increased frequency of ICOS for anti-CTLA-4 therapycancerimmunolres.aacrjournals.org/content/canimm/early/2013/07/31/... · biomarker for anti-CTLA-4 therapy, ... and red blood cells

Documents

NKTR-214 plus NKTR-262, a Scientifically-Guided … signaling to favor the CD122 Receptor (IL-2Rβγcomplex) Eliminates over-activation of IL-2 ... 100 Days * * Vehicle Anti-CTLA-4

NKTR-214 plus NKTR-262, a Scientifically-Guided … signaling to favor the CD122 Receptor (IL-2Rβγcomplex) Eliminates over-activation of IL-2 ... 100 Days * * Vehicle Anti-CTLA-4

Documents

Cell Therapy Business Entity - s3.amazonaws.com target discovery and validation platforms ... next-gen CTLA-4 CTLA-4 (antagonist) AGEN2034 PD-1 (antagonist) CD-137 (agonist) TIGIT

Cell Therapy Business Entity - s3.amazonaws.com target discovery and validation platforms ... next-gen CTLA-4 CTLA-4 (antagonist) AGEN2034 PD-1 (antagonist) CD-137 (agonist) TIGIT

Documents

2010 CTLA Annual Conference

2010 CTLA Annual Conference

Documents

Evaluation Of CTLA-4 Blockage Therapy With Metronomic

Evaluation Of CTLA-4 Blockage Therapy With Metronomic

Documents

Impact of CTLA-4 blockade in conjunction with metronomic ... 2017… · Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth Karla

Impact of CTLA-4 blockade in conjunction with metronomic ... 2017… · Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth Karla

Documents

Melanoma immunoterapia un paso más(pd 1 y ctla-4)

Melanoma immunoterapia un paso más(pd 1 y ctla-4)

Health & Medicine

Imaging in immuno-oncology Understanding novel response … · 2019-11-28 · Blocking CTLA-4 and PD-1/PD-L1 checkpoint signaling through antibody binding relieves inhibition

Imaging in immuno-oncology Understanding novel response … · 2019-11-28 · Blocking CTLA-4 and PD-1/PD-L1 checkpoint signaling through antibody binding relieves inhibition

Documents

Terapias anti CTLA-4 - · PDF fileTerapias anti CTLA-4 ... Paclitaxel/carboplatin ± ipilimumab NSCLC (n = 210) irPFS SCLC ... Week after initial dose 1,272 1,124 975 827

Terapias anti CTLA-4 - · PDF fileTerapias anti CTLA-4 ... Paclitaxel/carboplatin ± ipilimumab NSCLC (n = 210) irPFS SCLC ... Week after initial dose 1,272 1,124 975 827

Documents

CTLA-4- A Negative Regulator of Autoimmune Disease

CTLA-4- A Negative Regulator of Autoimmune Disease

Documents

THE ROLE OF CTLA-4 IN HEALTH AND AUTOIMMUNE DISEASE

THE ROLE OF CTLA-4 IN HEALTH AND AUTOIMMUNE DISEASE

Documents

2012 Conference on Teaching and Learning in Accounting (CTLA) Presented by:

2012 Conference on Teaching and Learning in Accounting (CTLA) Presented by:

Documents

Assessment of pharmacology and toxicology of anti-CTLA-4 ... · Assessment of pharmacology and toxicology of anti-CTLA-4 antibody (ADU-1604) in non-human primates ... (ADU-S100),

Assessment of pharmacology and toxicology of anti-CTLA-4 ... · Assessment of pharmacology and toxicology of anti-CTLA-4 antibody (ADU-1604) in non-human primates ... (ADU-S100),

Documents